Αποτελέσματα Αναζήτησης
Prostatic artery embolization (PAE) consists of blocking the arteries supplying the prostate to treat benign prostate hypertrophia (BPH). Its effectiveness on both urinary symptoms and flowmetric parameters has now been amply demonstrated by around ...
20 Αυγ 2021 · Clinical, laboratorial, and urodynamic findings of prostatic artery embolization for the treatment of urinary retention related to benign prostatic hyperplasia. A prospective single-center pilot study .
Several treatments are available for BPH, including medications such as α-blockers and 5α-reductase inhibitors and surgical options including trans-urethral resection of the prostate and prostatectomy.
26 Ιουλ 2019 · Prostatic artery embolization is emerging as an effective and safe treatment of symptomatic benign prostatic hyperplasia. Symptomatic benign prostatic hyperplasia is a common condition in the aging population that results in bothersome lower urinary tract symptoms and decreased quality of life.
First, it can help to identify the IVA origin, investigate accessory prostatic branches and collateral circulation to avoid non-target embolization; also, it can show the percentage of the prostate that is filled by a specific prostatic artery.
26 Ιουν 2021 · In patients receiving 5-alpha reductase inhibitors (eg, finasteride), sexual dysfunction is expected. Some patients succumb to a series of serious adverse events composed of irreversible sexual dysfunction, mood alterations, and neurologic and cognitive complaints that persist despite drug withdrawal [5].
PAE has been shown to have fewer side effects than other widely used treatments for BPH such as transurethral resection of the prostate (TURP) surgery, which is associated with incontinence, retrograde ejaculation, and erectile dysfunction issues in men.
